United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market (2025-2031) Outlook | Growth, Revenue, Trends, Industry, Analysis, Size, Forecast, Value, Share & Companies

Market Forecast By Type (2™ Fl, 3™ Fl, 3™ Sl, 6™ Sl), By Application (Infant Formula, Functional Food & Beverages, Food Supplement), By Concentration (Neutral, Acidic) And Competitive Landscape
Product Code: ETC4538021 Publication Date: Jul 2023 Updated Date: Sep 2025 Product Type: Report
Publisher: 6Wresearch No. of Pages: 85 No. of Figures: 45 No. of Tables: 25

United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Synopsis

The United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market is emerging as a significant segment within the broader functional food and nutraceutical industry. HMOs are complex carbohydrates naturally found in breast milk, and they offer various health benefits, including supporting the development of a healthy gut microbiome and enhancing the immune system. The increasing awareness of the importance of early-life nutrition and the role of HMOs in infant formula and dietary supplements has fueled market growth. The UAE rising birth rate and the government`s efforts to promote breastfeeding have further accelerated the demand for HMO-based products.

Drivers of the Markets

The UAE Human Milk Oligosaccharides (HMO) market is experiencing robust growth due to a combination of factors. Firstly, there is a growing awareness and understanding of the health benefits of HMOs, which are naturally occurring in human breast milk. These complex sugars have been found to play a crucial role in promoting infant gut health, strengthening the immune system, and providing other health advantages. As a result, there is an increasing demand for HMO-based infant formula and dietary supplements, especially in a country where infant nutrition is a significant concern. Secondly, the UAE thriving healthcare and research sectors are actively exploring HMOs` applications, further driving the market. Additionally, manufacturers in the UAE are investing in research and development to create innovative HMO products and cater to the rising demand, resulting in a significant market boost.

Challenges of the Markets

The HMO market faces complexities in replicating the natural composition of human milk, ensuring the safety and efficacy of synthetic HMOs, and meeting the growing demand for infant formula enriched with HMOs while complying with stringent regulations.

COVID-19 Impact on the Market

The Human Milk Oligosaccharides (HMO) market in the UAE experienced challenges during the COVID-19 pandemic, impacting the infant formula and functional food sector. Disruptions in manufacturing, regulatory considerations, and changing consumer preferences initially affected the HMO industry. The post-pandemic phase saw a resurgence in demand, with increased interest in HMO-enriched products for infant nutrition and gut health.

Key Players of the market

Key players in the UAE Human Milk Oligosaccharides (HMO) market include Jennewein Biotechnologie GmbH and Inbiose NV. Jennewein Biotechnologie GmbH, a global biotechnology company, has played a crucial role in supplying HMOs for various infant formula applications in the UAE. Inbiose NV, a biotech company specializing in the production of specialty carbohydrates, has also significantly contributed to the HMO market by offering innovative solutions for the food and nutrition industry in the UAE.

Key Highlights of the Report:

  • United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Outlook
  • Market Size of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market, 2024
  • Forecast of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market, 2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Revenues & Volume for the Period 2021-2031
  • United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Trend Evolution
  • United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Drivers and Challenges
  • United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Price Trends
  • United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Porter's Five Forces
  • United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Industry Life Cycle
  • Historical Data and Forecast of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume By Type for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume By 2?? Fl for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume By 3?? Fl for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume By 3?? Sl for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume By 6?? Sl for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume By Application for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume By Infant Formula for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume By Functional Food & Beverages for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume By Food Supplement for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume By Concentration for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume By Neutral for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume By Acidic for the Period 2021-2031
  • United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Import Export Trade Statistics
  • Market Opportunity Assessment By Type
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By Concentration
  • United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Top Companies Market Share
  • United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Competitive Benchmarking By Technical and Operational Parameters
  • United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Company Profiles
  • United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Overview

3.1 United Arab Emirates (UAE) Country Macro Economic Indicators

3.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 & 2031F

3.3 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market - Industry Life Cycle

3.4 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market - Porter's Five Forces

3.5 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Concentration, 2021 & 2031F

4 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about the health benefits of human milk oligosaccharides (HMOs) for infants

4.2.2 Growing demand for organic and natural infant nutrition products in the UAE

4.2.3 Rising disposable income and changing lifestyles leading to higher spending on premium infant formula products

4.3 Market Restraints

4.3.1 High production costs associated with extracting and synthesizing human milk oligosaccharides

4.3.2 Limited availability of human milk sources for extraction of HMOs

4.3.3 Stringent regulations and quality standards governing infant nutrition products in the UAE market

5 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Trends

6 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market, By Types

6.1 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market, By Type

6.1.1 Overview and Analysis

6.1.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Type, 2021-2031F

6.1.3 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 2?? Fl, 2021-2031F

6.1.4 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3?? Fl, 2021-2031F

6.1.5 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3?? Sl, 2021-2031F

6.1.6 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 6?? Sl, 2021-2031F

6.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market, By Application

6.2.1 Overview and Analysis

6.2.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Infant Formula, 2021-2031F

6.2.3 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Functional Food & Beverages, 2021-2031F

6.2.4 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Food Supplement, 2021-2031F

6.3 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market, By Concentration

6.3.1 Overview and Analysis

6.3.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Neutral, 2021-2031F

6.3.3 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Acidic, 2021-2031F

7 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Import-Export Trade Statistics

7.1 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Export to Major Countries

7.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Imports from Major Countries

8 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Key Performance Indicators

8.1 Research and development investment in HMO technology and innovation

8.2 Adoption rate of HMO-enriched infant formula products by UAE consumers

8.3 Number of partnerships and collaborations between HMO manufacturers and infant nutrition companies in the UAE

9 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market - Opportunity Assessment

9.1 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Concentration, 2021 & 2031F

10 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market - Competitive Landscape

10.1 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenue Share, By Companies, 2024

10.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All